WolverHeme Happy Hour cover image

Episode 13: You get blinatumomab! You get blinatumomab!

WolverHeme Happy Hour

00:00

BLIN at Tumumab: The Best Chemotherapy for Hyper C VAD

I think there's a lot of compelling arguments, you know, given with certain patients to choose one regimen versus the other. These are completely different chemo therapy backbones. It might be that the myelos suppression with a hyper C VAD just completely knocks out your effector cells. And it's become, and you may not see as much in the way of BLIN at Tumumab benefit.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app